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(DRESS) Secondary to Quetiapine in an Elderly PatientqTo the Editor:
A 63-year-old male was diagnosed with B cell lymphoma and
completed chemotherapy in 2006 without relapse. Quetiapine
was prescribed for bipolar disorder in April 2011 until the patient
complained of skin rashes and lymph node enlargement for 1
month. Further blood examination showed eosinophilia (2016/
mL) and thrombocytopenia (106,000/mL). His RegiSCAR score1
was three and was a possible case of drug reaction with eosino-
philia and systemic symptoms (DRESS). As a result, we changed
quetiapine to olanzapine without other intervention. The skin
rash resolved in 1 month with normalization of laboratory
values, and his mood remained stable. Olanzapine was used until
the patient died of recurrent lymphoma in 2012. Quetiapine has
been approved as a treatment for schizophrenia and bipolar dis-
order, and it is commonly used to control behavioral distur-
bances in geriatric cognitive disorders. Following a review of
the literature, this is the ﬁrst report of DRESS after quetiapine
use. The presenting symptoms in almost all patients were skin
rash, liver involvement, eosinophilia, and lymphadenopathy2.
The etiology of DRESS remains unknown, but suspected factors
include reactivation of viral infections, genetic predisposition,
and impaired drug metabolism pathways in certain patients3.
Immune-mediated systems probably play an important role
through the attraction of eosinophil by the interleukin-5 released
from activated drug-speciﬁc T lymphocytes4, but the exact path-
ogenic mechanism is still unknown. However, because elderly
patients are particularly vulnerable to adverse drug reactions, cli-
nicians should be aware of the potential for DRESS in association
with quetiapine.q The authors declare that they have no ﬁnancial or non-ﬁnancial conﬂicts of
interest related to the subject matter or materials discussed in the article.
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